Navigation Links
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
Date:11/12/2010

FRIDAY, Nov. 12 (HealthDay News) -- Patients with a certain type of leukemia who had insufficient vitamin D levels when their cancer was diagnosed saw their disease progress much faster and were two times more likely to die than those with adequate vitamin D levels, a new study finds.

Researchers also discovered that increasing vitamin D levels in patients was linked to longer survival times, even after controlling for other factors associated with leukemia progression.

This is an important finding for both patients and doctors, according to the researchers at the Mayo Clinic in Rochester, Minn. and the University of Iowa.

The disease -- chronic lymphocytic leukemia (CLL) -- is cancer of the white blood cells (lymphocytes) and mainly affects adults. Although CLL is often diagnosed at an early stage, the standard approach is to wait until patients develop symptoms before beginning chemotherapy, explained study author and hematologist Dr. Tait Shanafelt.

"This watch-and-wait approach is difficult for patients because they feel there is nothing they can do to help themselves," Shanafelt said in a Mayo news release. "It appears vitamin D levels may be a modifiable risk factor for leukemia progression. It is simple for patients to have their vitamin D levels checked by their physicians with a blood test. And if they are deficient, vitamin D supplements are widely available and have minimal side effects."

This study of 390 CLL patients found that 30 percent of them had insufficient vitamin D levels (less than 25 nanograms per milliliter) at the time of cancer diagnosis. After a median follow-up of three years, patients with insufficient vitamin D levels were 66 percent more likely to have disease progression and to require chemotherapy. They also had a twofold increased risk of death, compared to those with adequate vitamin D levels.

Similar findings were seen in a different group of CLL patients who were followed for 10 years, according to the researchers.

"This tells us that vitamin D insufficiency may be the first potentially modifiable risk factor associated with prognosis in newly diagnosed CLL," Shanafelt said.

The researchers are planning another study to see if reversing low vitamin D levels in patients will improve their prognosis.

The study appears online in the journal Blood.

More information

The Leukemia and Lymphoma Society has more about chronic lymphocytic leukemia.

-- Robert Preidt

SOURCE: Mayo Clinic, news release, Nov. 4, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Finds Vitamins E and C Dont Reduce Cataract Risk in Men
2. Vitamin D No Magic Bullet for Osteoarthritis
3. Vitamin E May Pose Slight Bleeding-Stroke Risk
4. Insufficient vitamin D levels in CLL patients linked to cancer progression and death
5. Genetics May Play Role in Vitamin E Levels
6. New clinical trial explores role of vitamin D in preventing esophageal cancer
7. Vigilance Against Skin Cancer May Lead to Lack of Vitamin D
8. Vitamin D deficiency linked to lung transplant rejection
9. Can Vitamin B12 Reduce Alzheimers Risk?
10. Vitamin D-ficiency common among orthopaedic surgery
11. Using cassava to address vitamin A deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
(Date:2/27/2017)... , ... February 27, 2017 , ... The threat of ... to work for a company involved in the underground testing of nuclear weapons. Years ... for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical ...
(Date:2/27/2017)... ... 2017 , ... Orange County dentist, Dr. A. Rassouli, comments on ... when the bacteria in plaque infect the gums and other tissues supporting the teeth. ... planing or SRP, and can include surgical therapies if the condition has led to ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate smart media ... system brings songs, movies, TV shows and much more apps for user exploration. Its ... An immersive view of 1280 x 720 provides crisp images with remarkable clarity and ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
(Date:2/27/2017)... N.J. and PETACH TIKVAH, Israel ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... appointments of June S. Almenoff , M.D., Ph.D., ... to its Board of Directors.  "Dr. ... executives whose appointments come at an exciting time for ...
Breaking Medicine Technology: